Corbus Pharmaceuticals Holdings, Inc. share price logo

Corbus Pharmaceuticals Holdings, Inc. Share Price

NASDAQ: CRBP

Small Cap

$9.33

-0.17

(-1.79%)

as on

Corbus Pharmaceuticals Holdings, Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $9.05
    $9.59
    downward going graph

    3.00%

    Downside

    2.79%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.64
    $56.93
    downward going graph

    50.27%

    Downside

    510.18%

    Upside

    downward going graph

Corbus Pharmaceuticals Holdings, Inc. share price movements today

Previous Close
$9.50
Open
$9.58
Volume
192.8K
Day's Low - High
$9.05 - $9.59
52 Week Low - High
$4.64 - $56.93

Corbus Pharmaceuticals Holdings, Inc. Historical Returns

1 Month Return
+ 2.7 %
3 Month Return
+ 7.59 %
1 Year Return
-82.98 %
3 Year Return
+ 52.54 %
5 Year Return
-83.93 %

Corbus Pharmaceuticals Holdings, Inc. Stock Fundamentals & Key Indicators

Check Corbus Pharmaceuticals Holdings, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$116.4M

EPS (TTM)

-5.63

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.31

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-66.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

2230000.00%

Corbus Pharmaceuticals Holdings, Inc. Stock Valuation

Track how Corbus Pharmaceuticals Holdings, Inc. P/E has moved over time to understand its valuation trends.

Corbus Pharmaceuticals Holdings, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Today (-15.31x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (-0.36x)

March 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -15.31x

Corbus Pharmaceuticals Holdings, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corbus Pharmaceuticals Holdings, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$116.4M-83.93%-15.310.00%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Corbus Pharmaceuticals Holdings, Inc. Stock including INR - Dollar returns

The Corbus Pharmaceuticals Holdings, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Corbus Pharmaceuticals Holdings, Inc. investment value today

Current value as on today

₹21,703

Returns

₹78,297

(-78.3%)

Returns from Corbus Pharmaceuticals Holdings, Inc. Stock

₹83,283 (-83.28%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Corbus Pharmaceuticals Holdings, Inc. Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Corbus Pharmaceuticals Holdings, Inc.. Average target price of $40.67

Corbus Pharmaceuticals Holdings, Inc. Share Price Target

Get share price movements and forecasts by analysts on Corbus Pharmaceuticals Holdings, Inc..

What analysts predicted

77.06%UPSIDE

Target Price

$40.67

Current Price

$9.33

Analyzed by

8 Analysts

Target

$40.67

Corbus Pharmaceuticals Holdings, Inc. target price $40.67, a slight upside of 77.06% compared to current price of $9.33. According to 8 analysts rating.

Corbus Pharmaceuticals Holdings, Inc. Stock's Interest Amongst Investors

Search interest for Corbus Pharmaceuticals Holdings, Inc. Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:18% versus previous 30 day period

Corbus Pharmaceuticals Holdings, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
-
-
-
1
-
-
-
0
-
-
Gross Profit
0
0
0
1
0
0
0
0
0
0
Operating Income
-17
-8
-9
-10
-9
-10
-15
-12
-19
-19
EBITDA
-17
-8
-9
-7
-9
-9
-13
-9
-16
-17
Interest Expense
0
1
0
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-17
-8
-10
-8
-6
-9
-13
-9
-16
-17
Income Tax Expense
0
0
0
0
0
-
-
-
-
-
Net Income
-17
-8
-10
-8
-6
-9
-13
-9
-16
-17
Net Profit Margin
0.00%
0.00%
0.00%
-594.27%
0.00%
0.00%
0.00%
-1354.89%
0.00%
0.00%

Corbus Pharmaceuticals Holdings, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
0
1
2
4
36
3
0
-
-
-
Gross Profit
-5
-13
-23
-43
36
3
0
-1
-31
0
Operating Income
-8
-19
-32
-56
-77
-122
-55
-34
-45
-48
EBITDA
-8
-19
-32
-56
-76
-121
-54
-38
-44
-37
Interest Expense
0
-
0
-
0
1
1
2
2
1
Depreciation
-
-
0
0
1
1
1
1
1
0
Income Before Tax
-8
-19
-32
-55
-71
-111
-45
-42
-44
-40
Income Tax Expense
0
0
0
1
-2
0
0
13
-
-
Net Income
-8
-19
-32
-55
-71
-111
-45
-55
-44
-40
Net Profit Margin
-1365.05%
-1046.27%
-1328.65%
-1154.48%
-197.69%
-2826.97%
-5166.42%
0.00%
0.00%
0.00%

Corbus Pharmaceuticals Holdings, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-8
-10
-8
-6
-9
-13
-9
-16
-17
Operating Cash Flow
-7
-7
-6
-7
-8
-13
-10
-16
-16
Investing Cash Flow
8
10
10
-98
-16
-15
8
18
17
Financing Cash Flow
0
0
-1
106
34
25
0
-
-
Change in Cash
1
2
2
0
9
-4
-2
1
1

Corbus Pharmaceuticals Holdings, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-19
-32
-55
-71
-111
-45
-42
-44
-40
Operating Cash Flow
-13
-27
-30
-45
-99
-48
-37
-36
-41
Investing Cash Flow
0
0
-2
-2
0
-73
30
35
-121
Financing Cash Flow
16
76
11
38
154
60
0
-2
166
Change in Cash
2
47
-20
-9
54
-60
-8
-3
3

Global Institutional Holdings in Corbus Pharmaceuticals Holdings, Inc.

Funds
Holdings
Cormorant Asset Management, LLC
19.38%
Orbimed Advisors, LLC
9.57%
Octagon Capital Advisors LP
9.1%
BlackRock Inc
6.9%
Vanguard Group Inc
5.48%

Insights on Corbus Pharmaceuticals Holdings, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 153.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 66.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, CRBP stock has moved down by -82.6%

About Corbus Pharmaceuticals Holdings, Inc.

corbus pharmaceuticals holdings, inc. (nasdaq: crbp) is a clinical stage drug development company targeting rare, chronic, and serious inflammatory and fibrotic diseases with clear unmet needs. the company's lead product candidate, resunab™, is a first-in-class, oral anti-inflammatory drug that acts to resolve inflammation through an endogenous pathway. resunab is scheduled to commence three phase 2 clinical trials in 2015 for the treatment of cystic fibrosis, diffuse systemic sclerosis ("scleroderma") and dermatomyositis, three diseases in which inflammation contributes to disease progression. resunab also has the potential to treat additional rare, inflammatory diseases.
OrganisationCorbus Pharmaceuticals Holdings, Inc.
Headquarters500 River Ridge Drive, Norwood, MA, United States, 02062
IndustryHealth Technology
CEODr. Yuval Cohen Ph.D.
E-voting on sharesClick here to vote

Key Management of Corbus Pharmaceuticals Holdings, Inc.

Name

Title

Mr. Sean F. Moran CPA, M.B.A.

Chief Financial Officer

Dr. Dominic Smethurst M.A., M.D.

Chief Medical Officer

Dr. Ian Hodgson B.Sc., Ph.D.

Chief Operating Officer

Mr. G. Scott Goeken J.D., M.S.

General Counsel & Corporate Secretary

Ms. Christina Bertsch M.A.

Vice President of Human Resources

Dr. Yuval Cohen Ph.D.

CEO & Director

FAQs

What is Corbus Pharmaceuticals Holdings, Inc. share price today?

Corbus Pharmaceuticals Holdings, Inc. share price today is $9.33 as on at the close of the market. Corbus Pharmaceuticals Holdings, Inc. share today touched a day high of $9.59 and a low of $9.05.

What is the 52 week high and 52 week low for Corbus Pharmaceuticals Holdings, Inc. share?

Corbus Pharmaceuticals Holdings, Inc. share touched a 52 week high of $56.93 on and a 52 week low of $4.64 on . Corbus Pharmaceuticals Holdings, Inc. stock price today i.e. is closed at $9.33,which is 83.61% down from its 52 week high and 101.08% up from its 52 week low.

What is Corbus Pharmaceuticals Holdings, Inc.'s market capitalisation today?

Corbus Pharmaceuticals Holdings, Inc. market capitalisation is $0.00T as on .

How to invest in Corbus Pharmaceuticals Holdings, Inc. Stock (CRBP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Corbus Pharmaceuticals Holdings, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Corbus Pharmaceuticals Holdings, Inc. Shares that will get you 0.1608 shares as per Corbus Pharmaceuticals Holdings, Inc. share price of $9.33 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Corbus Pharmaceuticals Holdings, Inc. Stock (CRBP) from India?

Indian investors can start investing in Corbus Pharmaceuticals Holdings, Inc. (CRBP) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Corbus Pharmaceuticals Holdings, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Corbus Pharmaceuticals Holdings, Inc. share’s latest price of $9.33 as on September 16, 2025 at 1:29 am IST, you will get 1.0718 shares of Corbus Pharmaceuticals Holdings, Inc.. Learn more about fractional shares .

What are the returns that Corbus Pharmaceuticals Holdings, Inc. has given to Indian investors in the last 5 years?

Corbus Pharmaceuticals Holdings, Inc. stock has given -83.93% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?